NOTCH2 and non-small cell lung carcinoma: Notch2 expression levels were approximately 40% higher in patients with advanced NSCLC compared to patients with stage I disease, and the incidence of Notch2 overexpression (22% increase) was significant in patients with disease recurrence (Chen et al., 2017).